About

About MimAbs Edelris Since its origins in 1960, Janvier Group has evolved into an essential partner in Drug Discovery, Preclinical Research and Bioproduction, providing clients worldwide with a unique combination of models and innovative solutions. We leverage the latest technologies to deliver well-characterized in vitro, in vivo, and custom-created models, as well as a range of tailored services to support your research from hit identification to candidate selection, with strong expertise in understanding mechanisms of action. Janvier Group operates internationally with a team of over 750 dedicated experts.